Key Record Dates
ClinicalTrials.gov Identifier: | NCT05184816 |
---|---|
Brief Title: | A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis |
First Submitted : | December 22, 2021 |
First Submitted that Met QC Criteria : | December 22, 2021 |
First Posted : | January 11, 2022 |
Last Update Submitted that Met QC Criteria : | January 30, 2024 |
Last Update Posted : | January 31, 2024 |